Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications

Md Nurul Huda,Md Nafiujjaman,Isaac G Deaguero,Jude Okonkwo,Meghan L Hill,Taeho Kim,Md Nurunnabi,Isaac G. Deaguero,Meghan L. Hill

DOI: https://doi.org/10.1021/acsbiomaterials.1c00217

2021-05-14

Abstract:Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They typically range in size from 30 to 150 nm in diameter. An exosome's surfaces can be bioengineered with antibodies, fluorescent dye, peptides, and tailored for small molecule and large active biologics. Exosomes have enormous potential as a drug delivery vehicle due to enhanced biocompatibility, excellent payload capability, and reduced immunogenicity compared to alternative polymeric-based carriers. Because of active targeting and specificity, exosomes are capable of delivering their cargo to exosome-recipient cells. Additionally, exosomes can potentially act as early stage disease diagnostic tools as the exosome carries various protein biomarkers associated with a specific disease. In this review, we summarize recent progress on exosome composition, biological characterization, and isolation techniques. Finally, we outline the exosome's clinical applications and preclinical advancement to provide an outlook on the importance of exosomes for use in targeted drug delivery, biomarker study, and vaccine development.This article has not yet been cited by other publications.

materials science, biomaterials

What problem does this paper attempt to address?

The main problems that this paper attempts to solve include:

1. **The potential of exosomes as diagnostic biomarkers**:
- Exosomes contain a variety of bioactive molecules, such as proteins, lipids, mRNA, receptors, immunomodulatory molecules and nucleic acids. These components can be used for early disease diagnosis, especially in the early detection of cancer, autoimmune diseases, infectious and inflammatory diseases.
- The specific protein biomarkers carried by exosomes can reflect abnormal conditions at the cellular level, so they have great potential in exosome - mediated detection techniques.

2. **The application of exosomes in targeted drug delivery**:
- Since exosomes have good biocompatibility, excellent payload capacity and low immunogenicity, they are regarded as a promising drug - delivery vehicle.
- Exosomes can achieve active targeting through surface modification (such as antibodies, fluorescent dyes, peptides, etc.), accurately deliver drugs to target cells or tissues, thereby improving the therapeutic effect and reducing side effects.
- Compared with synthetic polymer - based carriers, exosomes can better avoid rapid clearance in the blood and immune reactions, and prolong the circulation time of drugs.

3. **The role of exosomes in vaccine development**:
- Exosomes can be used as a platform for vaccine development, using their natural immunomodulatory properties to enhance the effectiveness of vaccines.
- By loading specific antigens or other immunostimulatory molecules, exosomes can induce an effective immune response in vivo, thus providing new ways to prevent and treat a variety of diseases.

4. **The progress of exosomes in clinical and pre - clinical applications**:
- The paper summarizes the latest progress in the composition, biological characteristics and separation techniques of exosomes, and outlines the applications of exosomes in clinical and pre - clinical studies.
- The author emphasizes the importance of exosomes in diagnosis, targeted drug delivery and vaccine development, and looks forward to future research directions.

In conclusion, this paper aims to explore the potential of exosomes in diagnosis, drug delivery and vaccine development and their clinical application prospects.